ATE459393T1 - Behandlung der sexuellen dysfunktion - Google Patents

Behandlung der sexuellen dysfunktion

Info

Publication number
ATE459393T1
ATE459393T1 AT06773098T AT06773098T ATE459393T1 AT E459393 T1 ATE459393 T1 AT E459393T1 AT 06773098 T AT06773098 T AT 06773098T AT 06773098 T AT06773098 T AT 06773098T AT E459393 T1 ATE459393 T1 AT E459393T1
Authority
AT
Austria
Prior art keywords
treatment
sexual dysfunction
sexual
dysfunction
Prior art date
Application number
AT06773098T
Other languages
English (en)
Inventor
Yong Choi
Thomas Steckler
Jonathan Sporn
Joseph Palumbo
James Lee
Original Assignee
Sk Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Holdings Co Ltd filed Critical Sk Holdings Co Ltd
Application granted granted Critical
Publication of ATE459393T1 publication Critical patent/ATE459393T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT06773098T 2005-06-22 2006-06-13 Behandlung der sexuellen dysfunktion ATE459393T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69280905P 2005-06-22 2005-06-22
PCT/US2006/023068 WO2007001841A1 (en) 2005-06-22 2006-06-13 Treatment of sexual dysfunction

Publications (1)

Publication Number Publication Date
ATE459393T1 true ATE459393T1 (de) 2010-03-15

Family

ID=37067408

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06773098T ATE459393T1 (de) 2005-06-22 2006-06-13 Behandlung der sexuellen dysfunktion

Country Status (12)

Country Link
US (1) US8552060B2 (de)
EP (1) EP1893291B1 (de)
JP (1) JP5298334B2 (de)
KR (1) KR101335942B1 (de)
AR (1) AR054790A1 (de)
AT (1) ATE459393T1 (de)
CA (1) CA2612672C (de)
DE (1) DE602006012670D1 (de)
ES (1) ES2344469T3 (de)
MY (1) MY145066A (de)
TW (1) TWI387452B (de)
WO (1) WO2007001841A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101335941B1 (ko) 2005-06-08 2013-12-04 에스케이바이오팜 주식회사 수면-각성 장애의 치료
CN106727486A (zh) 2009-06-22 2017-05-31 爱思开生物制药株式会社 治疗或预防疲劳的方法
AU2010316106B2 (en) * 2009-11-06 2015-10-22 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
EP2496227B1 (de) 2009-11-06 2019-05-22 SK Biopharmaceuticals Co., Ltd. Verfahren zur behandlung des fibromyalgie-syndroms
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
SI2968208T1 (sl) 2013-03-13 2023-02-28 Jazz Pharmaceuticals Ireland Limited, Zdravljenje katapleksije
WO2015010014A1 (en) 2013-07-18 2015-01-22 Jazz Pharmaceuticals International Iii Limited Treatment for obesity
US10888542B2 (en) 2014-02-28 2021-01-12 Sk Biopharmaceuticals Co., Ltd. Aminocarbonylcarbamate compounds
TWI655179B (zh) 2014-02-28 2019-04-01 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物
JP6466792B2 (ja) * 2015-07-03 2019-02-06 エスケー バイオファーマスティカルズ カンパニー リミテッド 注意欠陥／多動性障害（ａｄｈｄ）の治療方法
EP3509582B1 (de) * 2016-09-06 2023-12-20 Axsome Malta Ltd. Solvatform von (r)-2-amino-3-phenylpropyl-carbamat
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
MY202185A (en) 2016-10-06 2024-04-15 Jazz Pharmaceuticals Ireland Ltd Carbamoyl phenylalaninol compounds and uses therof
WO2018222954A1 (en) 2017-06-02 2018-12-06 Jazz Pharmaceuticals International Iii Limited Methods and compositions for treating excessive sleepiness
SG11202000817SA (en) 2017-07-31 2020-02-27 Jazz Pharmaceuticals Ireland Ltd Carbamoyl phenylalaninol analogs and uses thereof
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
WO2025006965A1 (en) 2023-06-29 2025-01-02 Axsome Therapeutics, Inc. Methods of administering solriamfetol to lactating women

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ285829B6 (cs) * 1993-06-10 1999-11-17 Eli Lilly And Company Použití derivátu tetrahydrobenz [c,d]indolu pro výrobu farmaceutického prostředku vhodného pro ošetřování sexuální dysfunkce
KR100197892B1 (ko) * 1994-09-09 1999-06-15 남창우 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법
KR0173862B1 (ko) 1995-02-11 1999-04-01 조규향 O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
US6228864B1 (en) * 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US20050203130A1 (en) 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
AU2005302589B2 (en) * 2004-10-28 2010-09-16 Sk Biopharmaceuticals Co., Ltd. Adjunctive therapy for depression
KR101335941B1 (ko) 2005-06-08 2013-12-04 에스케이바이오팜 주식회사 수면-각성 장애의 치료

Also Published As

Publication number Publication date
DE602006012670D1 (de) 2010-04-15
KR20080028445A (ko) 2008-03-31
US20090221553A1 (en) 2009-09-03
EP1893291A1 (de) 2008-03-05
WO2007001841A1 (en) 2007-01-04
AR054790A1 (es) 2007-07-18
MY145066A (en) 2011-12-15
TWI387452B (zh) 2013-03-01
JP2008546778A (ja) 2008-12-25
ES2344469T3 (es) 2010-08-27
EP1893291B1 (de) 2010-03-03
US8552060B2 (en) 2013-10-08
TW200727893A (en) 2007-08-01
KR101335942B1 (ko) 2013-12-04
JP5298334B2 (ja) 2013-09-25
CA2612672C (en) 2014-10-14
CA2612672A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
EP2182983A4 (de) Behandlung von amyloidogenen erkrankungen
DE602005025020D1 (de) Behandlung von entzündlichen erkrankungen durch el
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
ATE459393T1 (de) Behandlung der sexuellen dysfunktion
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
HUE032897T2 (hu) Összeállítás férfi szexuális zavar kezelésére
DK1720866T3 (da) Fremgangsmåde
ZA200710598B (en) Treatment of inflammatory conditions
EP1744751A4 (de) Verfahren zur behandlung von synucleinopathien
EP1845849A4 (de) Exoskelett für die beine
EP1874239A4 (de) Halb angetriebenes exoskelett der unteren extremität
DK1948177T3 (da) Anvendelse af flibanserin til behandling af præmenopausale seksuelle lystforstyrrelser
EP2160100A4 (de) Behandlung der transplantat-gegen-empfänger-krankheit
DK1706112T3 (da) Fremgangsmåder til at behandle en inflammatorisk-beslægtet sygdom
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
EP1830876A4 (de) Behandlung von hautmetastasen
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
EP2175873A4 (de) Behandlung von angstzuständen
FI20060154L (fi) Neurogeneratiivisten tilojen hoito
EP1965827A4 (de) Behandlung von entmyelinisierenden erkrankungen
ATE484279T1 (de) Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen
DE602006010449D1 (de) Behandlung von geflügel zwecks reduzierung der futon ascites
DE602006021192D1 (de) Visnadin zur Behandlung von Kopfhautjucken
GB0502656D0 (en) Treatment of metakaolin
FR2884647B1 (fr) Traitement de plaques de semi-conducteurs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties